For CTOs, bioinformatics leaders, and lab directors, choosing between building or buying genomics software is not just a technical decision. It is a long-term strategic investment. The real question is not build or buy. It is understanding the cost of build vs buying genomics software over time, including compliance, scalability, and operational risk. Why This Decision Is More Complex Than It...